Deep Tissue Pressure Injury (DTPI): Assessment, Documentation, and Management

Deep Tissue Pressure Injury (DTPI) FAQ

Deep tissue pressure injury is one of the most misunderstood categories in pressure injury classification. It presents differently from staged pressure injuries, evolves unpredictably, and requires a management approach that runs counter to how clinicians typically treat damaged tissue. Getting DTPI wrong — misclassifying it, debriding prematurely, or failing to monitor its evolution — leads to worse patient outcomes and documentation that cannot support the clinical decisions made.

What is a deep tissue pressure injury?

A DTPI is an area of intact or non-intact skin with localized damage to underlying soft tissue resulting from sustained pressure and/or shear. The visible presentation is persistent, non-blanchable deep red, maroon, or purple discoloration, or epidermal separation revealing a dark wound bed or blood-filled blister.

The critical distinction: the damage originates in deeper tissue layers — muscle and fascia — and manifests at the skin surface. Unlike staged pressure injuries where damage begins at the skin and progresses inward, DTPI starts deep and works outward. The surface presentation understates the severity of the underlying tissue damage.

DTPI can occur over bony prominences (sacrum, heels, ischial tuberosities) or under medical devices. It can develop rapidly — sometimes within hours of sustained pressure — and the visible discoloration may not appear until 24 to 72 hours after the causative pressure event.

How does DTPI differ from a Stage 1 pressure injury?

Both DTPI and Stage 1 pressure injuries involve intact skin with discoloration, but they represent fundamentally different levels of tissue damage.

Stage 1 presents as non-blanchable erythema of intact skin — the skin is red, but it is the expected red of surface-level inflammation. The damage is confined to the epidermis and superficial dermis. With appropriate pressure relief, Stage 1 injuries typically resolve without tissue breakdown.

DTPI presents as purple, maroon, or deep red discoloration that does not blanch. The color indicates damage to deeper structures — the discoloration comes from blood in damaged tissue below the skin surface, not from surface-level hyperemia. A DTPI may also present as a blood-filled blister or as intact skin that feels boggy, mushy, or warmer (and later cooler) than surrounding tissue compared to its adjacent area.

The distinction matters for two reasons. First, DTPI carries a much worse prognosis — it may evolve into a full-thickness wound (Stage 3 or Stage 4) as the deep tissue damage declares itself at the surface. Second, the management approach differs: Stage 1 injuries are treated with pressure redistribution and monitoring, while DTPI requires more aggressive monitoring and a deliberate decision not to intervene surgically.

For a complete overview of all pressure injury stages and their documentation requirements, see the pressure injury staging guide.

Why should you NOT debride a DTPI?

This is the most important clinical point about DTPI management, and the one most frequently violated: do not debride a deep tissue pressure injury.

The tissue visible at the surface of a DTPI may still be viable. The purple or maroon discoloration indicates damage, but the tissue has not declared itself — it may recover if pressure is relieved and perfusion is restored, or it may evolve into full-thickness necrosis. Debriding at this stage removes tissue that might have survived, converting a potentially recoverable injury into a definitive wound.

Premature debridement of DTPI:

Removes potentially viable tissue. The deep tissue damage may stabilize and partially recover with conservative management. Debridement eliminates that possibility.
Creates an open wound unnecessarily. Converting intact skin into an open wound introduces infection risk and creates a wound that requires ongoing management.
Worsens the staging classification. A debrided DTPI becomes an unstageable or Stage 3/4 pressure injury, which carries different reimbursement, quality metric, and regulatory implications.

The appropriate intervention is pressure redistribution, protection of the affected area, and vigilant monitoring. The wound will declare itself over days to weeks — either resolving or evolving into a staged injury that can then be managed according to its declared depth.

What is the monitoring protocol for DTPI evolution?

DTPI requires more frequent and more detailed monitoring than most pressure injuries because its trajectory is unpredictable. A DTPI may:

Resolve — the discoloration fades, the tissue remains intact, and no wound develops
Evolve into a Stage 3 or Stage 4 pressure injury — the overlying tissue breaks down as deep tissue necrosis declares itself at the surface
Become unstageable — if eschar or slough covers the wound bed after tissue breakdown, the full extent of damage cannot be determined until the wound is debrided

The monitoring protocol should include:

Daily visual assessment of the affected area, noting changes in color, size, temperature, and texture
Serial photographs at each assessment, with consistent lighting and positioning for comparison
Tissue palpation to assess for bogginess, fluctuance, or temperature changes compared to surrounding tissue
Repositioning compliance documentation showing the pressure redistribution schedule is being followed
Pain assessment — DTPI may be painful even when the skin is intact, and pain changes may signal evolution

What documentation is required for DTPI?

Complete documentation of a DTPI at every assessment must include:

Anatomical location — specific bony prominence or device contact point
Size — measured dimensions of the discolored area (length x width in centimeters)
Color description — purple, maroon, deep red, or description of blood-filled blister
Skin integrity — intact vs. non-intact, presence of blistering or epidermal separation
Temperature — warmer or cooler than adjacent tissue
Texture — firm, boggy, mushy, indurated
Pain assessment — presence, severity, and character of pain at the site
Photograph — clinical photo with measurement reference and date stamp
Repositioning and pressure redistribution plan — the specific interventions in place to relieve pressure at the affected site
Evolution tracking — comparison to prior assessments documenting whether the injury is stable, improving, or evolving

This level of documentation serves two purposes: it supports the clinical decision not to debride (which may be questioned on chart review), and it creates the longitudinal record needed to accurately restage the injury if it evolves. For LCD documentation requirements that apply when DTPI-related services are billed, see the LCD compliance guide.